Quantcast

Boca Pharmacal Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets

January 27, 2011

CORAL SPRINGS, Fla., Jan. 27, 2011 /PRNewswire/ — Boca Pharmacal, Inc. announced today that the U.S. Food and Drug Administration (FDA) approval and commercial launch of Hydrocodone Bitartrate and Acetaminophen (5mg/300mg, 7.5mg/300mg and 10mg/300mg) Boca’s generic version of Victory Pharma’s Xodol®. Hydrocodone Bitartrate and Acetaminophen is indicated for the relief of moderate to moderately severe pain

(Logo: http://photos.prnewswire.com/prnh/20110127/FL37887LOGO )

ABOUT BOCA PHARMACAL

Boca Pharmacal is a privately held pharmaceutical research and development company with full marketing and distribution. Founded in 1998 the company has focused on ability to offer lower volume items that may have been overlooked by some of the larger generic companies. Boca markets over 30 products and has a robust pipeline of lower cost generic alternatives.

SOURCE Boca Pharmacal, Inc.


Source: newswire



comments powered by Disqus